Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company¿s products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform.
| Last: | $0.1008 |
|---|---|
| Change Percent: | -3.54% |
| Open: | $0.101 |
| Close: | $0.1045 |
| High: | $0.101 |
| Low: | $0.1008 |
| Volume: | 1,000 |
| Last Trade Date Time: | 03/05/2026 11:16:03 am |
| Market Cap: | $17,627,135 |
|---|---|
| Float: | 3,810,446 |
| Insiders Ownership: | N/A |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Medical Equipment & Supplies |
| Sector: | Healthcare |
| Website: | https://www.ainos.com |
| Country: | US |
| City: | Houston |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Ainos Inc. warrants (NASDAQ: AIMDW).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
